Timothy P. Zannes's most recent trade in BioAffinity Technologies Inc was a trade of 8,641 Common Stock done . Disclosure was reported to the exchange on Jan. 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioAffinity Technologies Inc | Timothy P. Zannes | Secretary, EVP, Gen. Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 8,641 | 54,765 | - | 0 | Common Stock | |
| BioAffinity Technologies Inc | Timothy P. Zannes | Secretary, EVP, Gen. Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 04 Apr 2024 | 64,848 | 75,155 | - | 1.2 | 75,224 | Common Stock |
| BioAffinity Technologies Inc | Timothy P. Zannes | Secretary, EVP, Gen. Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2024 | 64,848 | 0 | - | - | Stock Option (right to buy) | |
| BioAffinity Technologies Inc | Timothy P. Zannes | Secretary, EVP, Gen. Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.58 per share. | 04 Apr 2024 | 29,031 | 46,124 | - | 2.6 | 74,900 | Common Stock |
| BioAffinity Technologies Inc | Timothy P. Zannes | Secretary, EVP, Gen. Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 6,688 | 10,307 | - | 0 | Common Stock | |
| BioAffinity Technologies Inc | Timothy P. Zannes | Secretary, EVP, Gen. Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 3,619 | 3,619 | - | 0 | Common Stock, par value $0.007 |